Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Experimental Hematology|October 2, 2022
Role of ASXL1 in hematopoiesis and myeloid diseasesXin Gao, Xiaona You, Nathalie Droin, et al.
Ejhaem|December 5, 2022
Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemiaTerrence Bradley, Deukwoo Kwon, Jorge Monge, et al.
Cancer|September 30, 2011
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndromeRami S Komrokji, Maria Corrales-Yepez, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2020
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic SyndromesQing Zhang, Mintallah Haider, Najla H Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2017
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid LeukemiaAbu-Sayeef Mirza, Jeffrey E Lancet, Kendra Sweet, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative NeoplasmsFranco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in MyelofibrosisFranco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.
American Journal of Hematology|December 23, 2016
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experiencePatrick T Griffin, Rami S Komrokji, Kendra Sweet, et al.
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic SyndromesMegan Melody, Najla Al Ali, Ling Zhang, et al.
Pageof 21